Studies inflammatory markers in people with psoriasis
Looks at immune signals in the skin of adults with psoriasis.
Plain-language title generated from the registry record
Registry title: Regulation of Inflammatory Genes in Psoriasis
Key facts
- Where
- Birmingham, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 19 and 99 years old?
Source: NCT03125655, who can take part
Where in United States
- The Kirklin ClinicBirmingham, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Alabama at Birmingham
- Trial code
- NCT03125655
- Record updated
- 6 April 2026
- Original description
Psoriasis is a chronic and recurrent skin disorder characterized by marked inflammatory changes in the skin. An extensive cytokine network including generated by activated dendritic cells and T cells mediates the formation of psoriatic lesions. These immune-response parameters can be used as markers in the severity and management of the disease after further in-depth studies.Read full original descriptionShow less
Regulation of Inflammatory Genes in Psoriasis
Psoriasis is a chronic and recurrent skin disorder characterized by marked inflammatory changes in the skin. An extensive cytokine network including generated by activated dendritic cells and T cells mediates the formation of psoriatic lesions. These immune-response parameters can be used as markers in the severity and management of the disease after further in-depth studies.
Inclusion: Clinical diagnosis of psoriasis; Must be age 19 or older; Must be Fitzpatrick skin type I, II, III, IV, V, VI.
Exclusion: Subjects who do not have photosensitive disease and are not on photosensitizing medications; Subjects with a history of keloids (who are more likely to develop hypertrophic scars following skin biopsy); Subjects who have an allergy to local anesthetics, antibiotics and/or anticoagulants; Subjects who are pregnant.